This led to the inhibition of GSK3B, which is a product of RAF-1 phosphorylation, resulting in a significant decrease in tumor volume and revealing the important role of this downstream signaling cascade in MTC [65]. The gene discussed is RAF1; the disease is medullary thyroid gland carcinoma.